Mylan N.V. (Nasdaq: MYL) announced that its U.S. subsidiary will launch the first generic to EpiPen Auto-Injector (epinephrine injection, USP) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Management Comments

BTIG Affirms Mylan (MYL) at 'Buy'; Generic EpiPen Highlights Challenges to U.S. Healthcare SystemAugust 29, 2016 2:22 PM Generic EpiPen to Hit Mylan (MYL) EPS by a Modest 2% - LeerinkAugust 29, 2016 10:08 AM Mylan's (MYL) Epipen4Schools Program is a Complicated Maze of Specialty Distribution Cos - Wells Fargo's MarisAugust 29, 2016 7:41 AM Mylan to Launch First Generic to EpiPen® Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand ProductAugust 29, 2016 6:00 AM Why All the Outcry About EpiPen Prices Now? It's Back to School TimeAugust 26, 2016 7:47 AM PCMA: 'It Was Mistake for Mylan (MYL) to Adopt Pricing Strategy Used Unsuccessfully by Valeant (VRX), Turing'August 25, 2016 3:05 PM Elijah Cummings Says Mylan's (MYL) Meager Discount Merely 'PR Move' August 25, 2016 10:42 AM Options with increasing volume: NYMX MYL ULTAAugust 25, 2016 9:43 AM Wall St. slips on healthcare, consumer names; Fed eyedAugust 25, 2016 9:10 AM Mylan (MYL) CEO says healthcare bubble 'going to burst'August 25, 2016 8:37 AM